Search Results - "Polisson, Richard"

Systemic sclerosis - continuing progress in developing clinical measures of response by FURST, Daniel, KHANNA, Dinesh, POLISSON, Richard, STRAND, Vibeke, MATUCCI-CERINIC, Marco, CLEMENTS, Philip, STEEN, Virginia, POPE, Janet, MERKEL, Peter, FOELDVARI, Ivan, SEIBOLD, James, PITTROW, David

“…Few randomized controlled trials (RCT) have shown a demonstrable treatment effect in systemic sclerosis (SSc), making it difficult to evaluate outcome measures…”
Get full text

Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial by Merkel, Peter A., Silliman, Nancy P., Denton, Christopher P., Furst, Daniel E., Khanna, Dinesh, Emery, Paul, Hsu, Vivien M., Streisand, James B., Polisson, Richard P., Åkesson, Anita, Coppock, John, van den Hoogen, Frank, Herrick, Ariane, Mayes, Maureen D., Veale, Douglas, Seibold, James R., Black, Carol M., Korn, Joseph H.

“…Objective To determine the validity, reliability, and feasibility of durometer measurements of skin hardness as an outcome measure in clinical trials of…”
Get full text

Case 29-2005: A 68-Year-Old Man with Periorbital Swelling, Rash, and Weakness by Polisson, Richard P, Crocker, Jonathan T, Mueller, Peter R, Harris, Nancy Lee, Duncan, Lyn M

“…A 68-year-old man noted a rash followed by periorbital swelling and muscular weakness. Several months before his hospital admission, he had had involuntary…”
Get full text

Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis by FURST, Daniel E, WEISMAN, Michael, PAULUS, Harold E, BULPITT, Kenneth, WEINBLATT, Michael, POLISSUN, Richard, ZAUG, Michel, KNEER, Johannes, VAN DER AUWERA, Philippe, STEVENS, Randall M

“…OBJECTIVE: To determine the optimal dose regimen of intravenous (IV) Ro 45-2081 (lenercept), a tumor necrosis factor receptor p55-Fc IgG1 fusion protein, in…”
Get full text

Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study by Warren, Julia T., Walkovich, Kelly J., Bolyard, Audrey Anna, Dickerson, Kathryn E., Walter, Jolan E., Cadavid, Diego, Chapa, Eloisa, Chen, Kelly, MacLeod, Richard, Peters, Katie, Polisson, Richard, Dale, David C.

Get full text

The rational initial clinical evaluation of the patient with musculoskeletal complaints by Phillips, A C, Polisson, R P

“…The differentiation of articular from nonarticular complaints and inflammatory from noninflammatory disorders can usually be made by clinical evaluation…”
Get more information

Calcification of entheses associated with X-linked hypophosphatemic osteomalacia by Polisson, R P, Martinez, S, Khoury, M, Harrell, R M, Lyles, K W, Friedman, N, Harrelson, J M, Reisner, E, Drezner, M K

“…We undertook a retrospective analysis of 26 patients with X-linked hypophosphatemic osteomalacia (or rickets), whose ages ranged from 1 to 62 years and who…”
Get more information

Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection by Polisson, R

“…Nonsteroidal anti-inflammatory drugs (NSAIDs) are prescribed frequently for patients with painful musculoskeletal conditions: Each year, physicians write…”
Get more information

Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease by MERKEL, P. A, POLISSON, R. P, CHANG, Y, SKATES, S. J, NILES, J. L

“…Two types of antineutrophil cytoplasmic antibodies (ANCA), antiproteinase 3 antibodies (anti-PR3) and antimyeloperoxidase antibodies (anti-MPO), are useful in…”
Get full text

Innovative therapies in osteoarthritis by Polisson, R

“…Until recently, osteoarthritis (OA) was classified as a mechanical wear-and-tear disorder of articular cartilage, for which only pain-modifying therapies such…”
Get full text

BLISS index for analyzing knee osteoarthritis trials data by Bellamy, Nicholas, Bell, Mary J, Pericak, Dan, Goldsmith, Charlie H, Torrance, George W, Raynauld, Jean-Pierre, Walker, Valery, Tugwell, Peter, Polisson, Richard

“…Abstract Objectives Different pain thresholds were investigated, using the WOMAC Pain Scale (WOMAC-P) to determine if they could differentiate between…”
Get full text

Iliopsoas bursitis: clinical features, radiographic findings, and disease associations by Toohey, A K, LaSalle, T L, Martinez, S, Polisson, R P

“…Inflammation of the iliopsoas bursa is a common manifestation of a wide array of inflammatory, degenerative, and traumatic musculoskeletal conditions. The…”
Get more information

Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose by Palmer, W E, Rosenthal, D I, Schoenberg, O I, Fischman, A J, Simon, L S, Rubin, R H, Polisson, R P

“…To quantify the activity of joint inflammation with magnetic resonance (MR) imaging and positron emission tomography (PET). Gadolinium-enhanced MR imaging and…”
Get more information

The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases by Merkel, P A, Chang, Y, Pierangeli, S S, Convery, K, Harris, E N, Polisson, R P

“…To determine the prevalence and clinical associations of anticardiolipin antibodies (aCL) in a blinded, controlled study of patients with a variety of…”
Get more information

The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT–OARSI by Bellamy, Nicholas, Bell, Mary J., Goldsmith, Charlie H., Pericak, Dan, Walker, Valery, Raynauld, Jean-Pierre, Torrance, George W., Tugwell, Peter, Polisson, Richard

“…Secondary analyses of a previously conducted 1-year randomized controlled trial were performed to assess the application of responder criteria in patients with…”
Get full text

A man with periorbital swelling, rash, and weakness by POLISSON, Richard P, CROCKER, Jonathan T, MUELLER, Peter R, HARRIS, Nancy Lee, DUNCAN, Lyn M

Get full text

CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL: Case 29-2005 by Cabot, Richard C, Harris, Nancy Lee, Shepard, Jo-Anne O, Ebeling, Sally H, Ellender, Stacey M, Peters, Christine C, Polisson, Richard P, Crocker, Jonathan T, Mueller, Peter R, Duncan, Lyn M

“…A 68-year-old man noted a rash followed by periorbital swelling and muscular weakness. Several months before his hospital admission, he had had involuntary…”
Get full text

Pseudoseptic reactions to Hylan viscosupplementation: diagnosis and treatment by Magilavy, Daniel B, McPherson, John M, Polisson, Richard

Get more information

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus by Petri, Michelle A., Mease, Philip J., Merrill, Joan T., Lahita, Robert G., Iannini, Mark J., Yocum, David E., Ginzler, Ellen M., Katz, Robert S., Gluck, Oscar S., Genovese, Mark C., Van Vollenhoven, Ronald, Kalunian, Kenneth C., Manzi, Susan, Greenwald, Maria W., Buyon, Jill P., Olsen, Nancy J., Schiff, Michael H., Kavanaugh, Arthur F., Caldwell, Jacques R., Ramsey‐Goldman, Rosalind, St. Clair, E. William, Goldman, Allan L., Egan, Rita M., Polisson, Richard P., Moder, Kevin G., Rothfield, Naomi F., Spencer, Robert T., Hobbs, Kathryn, Fessler, Barri J., Calabrese, Leonard H., Moreland, Larry W., Cohen, Stanley B., Quarles, Betty J., Strand, Vibeke, Gurwith, Marc, Schwartz, Kenneth E.

“…Objective To determine whether prasterone administration results in improvement or stabilization of systemic lupus erythematosus (SLE) disease activity and its…”
Get full text

Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires by Tugwell, P, Bombardier, C, Buchanan, W W, Goldsmith, C, Grace, E, Bennett, K J, Williams, H J, Egger, M, Alarcon, G S, Guttadauria, M

“…In a double-blind, randomized trial of methotrexate vs placebo in rheumatoid arthritis, the effect of treatment on physical, social, and emotional function was…”
Get more information